{{Rsnum
|rsid=1467199
|Gene=STAT1
|Chromosome=2
|position=191015776
|Orientation=plus
|GMAF=0.3352
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=STAT1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 49.2 | 43.1 | 7.7
| HCB | 31.1 | 48.9 | 20.0
| JPT | 29.5 | 52.3 | 18.2
| YRI | 38.1 | 41.3 | 20.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 31.1 | 48.9 | 20.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19644876
|Title=Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome
}}

{{PMID|17932559|OA=1
}} Association of STAT4 with rheumatoid arthritis in the Korean population.

{{PMID|18520591|OA=1
}} Sequence variants in host cell factor C1 are associated with Meniere's disease.

{{PMID|19019891|OA=1
}} STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk.

{{PMID|19753122|OA=1
}} Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk.

{{on chip | FTDNA2}}
{{on chip | FTDNA}}